Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 2
2007 1
2008 5
2009 5
2010 4
2011 3
2012 4
2013 6
2014 5
2015 7
2016 7
2017 14
2018 9
2019 8
2020 9
2021 9
2022 7
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo.
Kuduvalli SS, Daisy PS, Vaithy A, Purushothaman M, Muralidharan AR, Agiesh KB, Mezger M, Antony JS, Subramani M, Dubashi B, Biswas I, Guruprasad KP, Anitha TS. Kuduvalli SS, et al. Among authors: mezger m. Front Pharmacol. 2024 Jan 9;14:1322332. doi: 10.3389/fphar.2023.1322332. eCollection 2023. Front Pharmacol. 2024. PMID: 38264527 Free PMC article.
CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells.
Mohammadian Gol T, Kim M, Sinn R, Ureña-Bailén G, Stegmeyer S, Gratz PG, Zahedipour F, Roig-Merino A, Antony JS, Mezger M. Mohammadian Gol T, et al. Among authors: mezger m. Int J Mol Sci. 2023 Nov 8;24(22):16065. doi: 10.3390/ijms242216065. Int J Mol Sci. 2023. PMID: 38003255 Free PMC article.
A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo.
Kuduvalli SS, Daisy PS, Vaithy A, Purushothaman M, Ramachandran Muralidharan A, Agiesh KB, Mezger M, Antony JS, Subramani M, Dubashi B, Biswas I, Guruprasad KP, Anitha TS. Kuduvalli SS, et al. Among authors: mezger m. Front Pharmacol. 2023 Mar 21;14:1096614. doi: 10.3389/fphar.2023.1096614. eCollection 2023. Front Pharmacol. 2023. PMID: 37025487 Free PMC article.
Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas.
Eichholz T, Döring M, Giardino S, Gruhn B, Seitz C, Flaadt T, Schwinger W, Ebinger M, Holzer U, Mezger M, Teltschik HM, Sparber-Sauer M, Koscielniak E, Abele M, Handgretinger R, Lang P. Eichholz T, et al. Among authors: mezger m. Front Oncol. 2023 Feb 21;13:1064190. doi: 10.3389/fonc.2023.1064190. eCollection 2023. Front Oncol. 2023. PMID: 36895486 Free PMC article.
CRISPR medicine for blood disorders: Progress and challenges in delivery.
Mohammadian Gol T, Ureña-Bailén G, Hou Y, Sinn R, Antony JS, Handgretinger R, Mezger M. Mohammadian Gol T, et al. Among authors: mezger m. Front Genome Ed. 2023 Jan 6;4:1037290. doi: 10.3389/fgeed.2022.1037290. eCollection 2022. Front Genome Ed. 2023. PMID: 36687779 Free PMC article. Review.
Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies.
Ureña-Bailén G, Block M, Grandi T, Aivazidou F, Quednau J, Krenz D, Daniel-Moreno A, Lamsfus-Calle A, Epting T, Handgretinger R, Wild S, Mezger M. Ureña-Bailén G, et al. Among authors: mezger m. CRISPR J. 2023 Feb;6(1):5-16. doi: 10.1089/crispr.2022.0086. Epub 2023 Jan 20. CRISPR J. 2023. PMID: 36662546 Free PMC article.
106 results